Shilpa Medicare · NSE: SHILPAMED · BSE: 530549

Q2 FY23 results · Jul–Sep 2022

Shilpa Medicare reported revenue from operations of ₹262.91 crore (down 11.0% from Q2 FY22) and net loss of ₹18.58 crore for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.

Consolidated · ₹ crore
Item	Q2 FY23	Q2 FY22	YoY	Q1 FY23	QoQ
Revenue from operations	262.91	295.27	−11.0%	261.16	+0.7%
Other income	4.39	1.28	+242.1%	8.10	−45.9%
Total income	267.29	296.55	−9.9%	269.26	−0.7%
Profit before share of associates & JVs and tax	(20.20)	32.59	Turned loss	(3.34)	Loss widened
Share of profit/(loss) of associates & JVs	(2.20)	(1.14)		(0.73)
Net profit for the period	(18.58)	19.88	Turned loss	2.34	Turned loss
Attributable to shareholders of the company	(18.66)	19.96	Turned loss	0.85	Turned loss
EPS, basic (₹)	(2.15)	2.45	Turned loss	0.10	Turned loss
Net margin (%)	-7.1	6.7		0.9

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q2 FY23	Q2 FY22	YoY	Q1 FY23	QoQ
Revenue from operations	68.73	285.87	−76.0%	60.83	+13.0%
Other income	18.09	9.11	+98.6%	12.63	+43.2%
Total income	86.82	294.98	−70.6%	73.46	+18.2%
Profit before tax	(23.78)	60.98	Turned loss	4.05	Turned loss
Net profit for the period	(17.17)	43.62	Turned loss	108.08	Turned loss
EPS, basic (₹)	(1.98)	5.35	Turned loss	12.45	Turned loss
Net margin (%)	-25.0	15.3		177.7

Consolidated

Filed with BSE: 13 Nov 2022, 12:21 IST
Board meeting: 11 Nov 2022
Period: 01 Jul 2022 to 30 Sep 2022
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 13 Nov 2022, 12:21 IST
Board meeting: 11 Nov 2022
Period: 01 Jul 2022 to 30 Sep 2022
Review status: Unaudited
Source: XBRL filing on BSE